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With just 10% of South Africans needing
antiretroviral (ARV) drugs actually on
treatment, scaling up South Africa’s
ARV rollout is an urgent priority or it
will take ‘years and years’ to impact on
the ever-burgeoning demand.
This was the sober warning from 
Dr Francois Venter, Clinical Director of
the Reproductive Health and HIV
Research Unit at Witwatersrand
University, in delivering a critical
appraisal of the State’s ARV programme
at the second national AIDS conference
in Durban last month.
Echoeing the Treatment Action
Campaign’s call for treating 200 000
adults and children by next year, Venter
said that with about 500 000 (of the five
million HIV-positive South Africans)
needing ARVs, ‘the initial thinking is to
try and get just half of these on ARV’.
It was worrying that recently the
numbers of patients going onto ARVs
nationally had actually declined slightly.
‘We have to get the numbers up as soon
as possible. Instead of 20 per month
coming onto treatment at a particular
facility, we need 400,’ he added.
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Organization’s review of its Millennium
Development Goals this September.
The Durban conference was a chance
to respond on the AIDS front.
In the absence of a cure for AIDS, her
government was determined to back
strategies for sexual abstinence and
prevention. 
Even in New York, where she had
recently attended an international
health symposium, people were
astonished at ‘how many resources in
South Africa were being put into
fighting HIV/AIDS but are not being
harnessed’.
She said her department was not
‘chasing numbers (ARV recipients)’, but
rather seeking quality of care.  ‘When I
meet with my MECs all I ask is about
the quality of the service,’ she added.
Government was on target with an
AIDS-related treatment facility in every
province by the end of the year and
could ‘hold its head high’ on what it
had done about HIV/AIDS.
Morris rebuke
The minister’s sharp rebuke of
Professor Morris came while she was
fielding press questions, some of which
tackled her controversial views. 
She said of Morris’s request for
information about where the
government stood with its
comprehensive HIV/AIDS plan, ‘I
challenge you to answer your own
question,’ adding that Morris ‘should be
in a position to do so’ because she was
employed by her own Health
Department.
When Tshabalala’s Director-General,
Thami Mseleku, tried to calm matters
down by saying he thought Morris was
asking a logistical question, the minister
retorted ‘no, that is not what I heard her
say!’.  Interviewed later, Morris
expressed shock and bewilderment.
‘I need to slot her department in to
the presentation schedule of the
conference – that’s what I was after,’ she
told Izindaba.
No clear answers for SAMJ
Izindaba asked the minister whether she
could provide a ‘straight yes or no
answer, followed by her reasons, as to
whether she believed the benefits of
ARVs outweighed the costs.  Her
response came only after an
intervention by Mseleku (who said
science had no clear answer) and a
deferral to Medical Research Council
President-Elect, Professor Anthony
Mbewu.  Mbewu said it was ‘a tragedy’
that in spite of hundreds of clinical ARV
trials by multinational companies using
South Africans over the past 15 years,
‘we don’t have the data on the side-
effects and long-term prognosis (of
ARVs)’.
‘If you were to say what are the
benefits of ARVs per se, I’d say ask the
clinicians – but research is still going on
in terms of the benefit in say, 5 - 20
years,’ he added.  South Africa was
learning from the international context,
with Brazil already facing the
difficulties of ‘Regimen 2’, he said.
‘The benefits have still to be fully
quantified, but there’s a lot of active
research,’ he added.  Tshabalala-
Msimang then picked up on the theme
of foreign research exploitation before
saying that perhaps ARVs worked
better in a First World context, ‘whereas
in a South African context you must
understand it’s maybe a difficult
question – there are first and second
economies and we don’t want to
desegregate these economies – this is
why we are taking a very hard line on
the registration of all clinical trials
taking place here’.
Citing recent unnamed foreign
microbicide research that allegedly left
52 women HIV-positive, she added, ‘ if
they don’t succeed, tomorrow they’re
gone and the public sector has to take
care of the patients’.
She added with emphasis, ‘I hope
some of those who benefit from this will
also take note of our firm stand on
foreign trials’.
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However, he qualified the arithmetic
by saying it was important to ‘look at
the absolute need, versus the numbers’,
citing the Free State Province where
more than half of the people introduced
into and staged through the ARV
programme had died.
Too little, too late for many
Clinician after clinician at the
conference related how huge numbers
of end-stage AIDS patients were being
lost because of coming onto the ART
programme ‘too late’ with CD4 cell
counts way below the recommended
200 level. Anglo-American reported that
74% of their patients were starting
treatment too late.  Venter said that
across South Africa, 67% of patients on
ARVs were female with an average age
of 35 while men were on average 10
years older.
While most patients suffered ARV
side-effects (mainly headaches,
dizziness, rash, nausea, peripheral
neuropathy), these usually resolved
within a month or two.
‘The drugs are toxic. But the disease is
toxicer!’ he said, quoting a colleague, 
Dr Fransesca Conradie, to loud
applause from his audience.
Criticising what he called ‘adherence
overkill’, Venter said the ‘real numbers’
of patients would only flood in for
treatment in 3 - 4 years’ time.
He believed that it was ‘just not
practical to expect 95% adherence’. ‘I
mean, come on, 8 patient visits before
beginning them on ART; you can get a
kidney transplant in that time!’ he
joked.  Both Venter and the latest joint
Aids Law Project/TAC assessment of
the government’s HIV/AIDs
Operational Plan concluded that the
lack of human resources, particularly
health care workers trained to
administer paediatric treatment, and
pharmacists, was alarming.  ‘The
paediatric numbers are a disaster
because doctors and nurses are terrified
of children (more complicated to treat),’
they said.
Children worst off
Dr Tammy Myers of the Harriet Shezi
Paediatric HIV/AIDS Clinic at the Chris
Hani Baragwanath Hospital called for a
paediatric section to be established
within the HIV/AIDS unit of the
national health department in order to
redress the ‘huge inequities with the
most vulnerable’.
Only 3 000 children were receiving
ART in public hospitals in South Africa,
when the figure should be nearer 50 000,
given the scale and duration of the
rollout. Far too many children were
dying because HIV diagnoses came too
late while just 6% of her patients were
receiving supplementary nutrition from
the State.
Venter said that nutrition and other
supplementary treatments were key in
helping delay the onset of AIDS, but
questioned whether dieticians were
necessary on an ARV site before putting
patients on treatment.
State gives overview
Dr Nomonde Xundu, the country’s new
HIV/AIDS chief, later told a press
conference that having a dietician was
not a prerequisite for accreditation of an
official ARV site (of which she revealed
there were 143 so far).
Giving an official overview promised
earlier by her health minister, Xundu
said 12 000 doctors and 9 400 nurses,
with 21 000 minimum-stipend or
voluntary home-based carers, formed
the backbone of the State delivery
system, using 340 hospitals linked to 
4 302 primary health care centres.
Almost all of these facilities provided
some HIV/AIDs-related services with
73% offering voluntary counselling and
testing (VCT).
In the past 18 months 1.2 million
people had been counselled, with 71%
taking HIV tests.  By the end of April
this year, an estimated 50 000 people had
begun State-provided ART, with 10% of
these being paediatric cases. Adherence
levels stood at 95% with 436 079 CD4
cell counts done and 63 384 viral load
tests conducted.  In the Prevention of
Mother to Child Transmission
Programme (PMTCTP), 530 000 patients
had paid their first visit to a clinic, with
95 500 tested and a 3-year HIV-free
infant survival rate so far.
Only 3 000 children were
receiving ART in public
hospitals in South Africa,
when the figure should be
nearer 50 000, given the scale
and duration of the rollout.
Criticising what he called
‘adherence overkill’, Venter
said the ‘real numbers’ of
patients would only flood in for
treatment in 3 - 4 years’ time.
Venter’s conclusion at the end
of his appraisal was that it
was ‘too early to call this a
successful failure – but the
clock is ticking!’
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She described the demand as ‘huge’
and frankly admitted that State capacity
was ‘questionable’ – with Venter
illustrating this by citing the 30% of the
health care posts in the North West
Province that stand unfilled.  However,
Venter said the commitment of health
care workers in that province was
‘superb’ because it had the best ratio of
patients on ARVs versus those needing
ARVs.
He said that at Klerksdorp Hospital
alone, 600 new ART patients were taken
on in the last 6 months.  State
HIV/AIDS epidemiology chief, Dr
Lindiwe Makabula said that from April
last year to March this year the number
of CD4 cell count tests nationally had
risen from 14 135 to 54 759.
Venter’s conclusion at the end of his
appraisal was that it was ‘too early to
call this a successful failure – but the
clock is ticking!’
Too few pregnant women access
service
Professor James McIntyre, Director of
the Perinatal HIV Research Unit at the
University of the Witwatersrand, told
delegates that 25% of the 1 million
South Africans who became pregnant
annually were HIV-positive and that
20% of these women had CD4 cell
counts of below 200.
‘Service coverage remains very low
with less than 8% of HIV- positive
pregnant women nationally accessing
them,’ he revealed.  He pleaded for an
increase of CD 4 cell count capacity at
PMTCT sites so that pregnant women
who qualified could access ART.
Best private practice
Anglo-American’s HIV/AIDS chief, Dr
Brian Brink, said his company’s goal
was to have half of all their 145 000
workers (HIV prevalence 23%) enrolled
in VCT by the end of the year.
Uptake last year had been
‘disappointing’ at 21% (with large
percentage variations between mines).
Free ARVs had been provided at 78
accredited sites since November 2002
with 2 936 employees on ART (only
2.4% declining treatment).  Contrary to
the State, Anglo began ART at a CD4
cell count of 250 (or even between 250
and 350 if a stage 3 disease was present)
and was experiencing 7.5 deaths per 100
person-years on treatment with 95% of
employees on ART able to return to
work.
Some 41% of ART patients
experienced adverse events, but most
were mild with just 10% serious (i.e.
49% bone marrow suppression and 24%
liver toxicity).  A full 92% of their
patients said they had not missed their
tablets in the past 3 days and their
median CD4 cell counts rose steadily
over 12 months.
Brink said two-thirds of patients came
onto ART with initial CD4 cell counts of
less than 100, which translated into a
mortality rate of 12% among these
workers.  Most of these deaths occurred
in the first 90 days.
The mining giant had managed to
bring the cost of ART in the first year
down to R1 234 per person with Anglo-
Coal having ‘broken the R1 000 per
person barrier’.
The overall result was a dramatic
reduction in absenteeism, reduced
hospital and outpatient time.  Over the
first year of treatment, 70% of the
company’s HIV/AIDS outlay was
covered by the reduction in
absenteeism, with all outlay being
covered as time went by.
One particular mine, Goedehoop
Colliery, with 1 177 staff of which 18%
tested HIV-positive and of which 37%
(65 patients) qualified for ART, now had
99% of them well and back at work.
The mine had reset its VCT counter to
zero.
‘No one at Goedehoop gets sick or
dies of AIDS anymore. If we can do it in
one workplace community, there is no
reason why it cannot be done in any
community,’ Brink said, to loud
applause.  According to the TAC’s
appraisal, there are between 50 000 and
60 000 patients on ART in the private
sector (as at the end of March 2005).
Huge provincial disparities
The TAC report said that while the
State’s figures ‘appeared to demonstrate
significant progress’, they were
misleading because the bulk of the ARV
rollout was happening in KwaZulu-
Natal, Gauteng, the Western Cape and
the North West with the remaining
provinces lagging way behind.
The national health department
needed to provide urgent support to
Limpopo, Mpumalanga and the Eastern
Cape while the Northern Cape and Free
State had adopted a ‘very slow,
cautionary approach’.
Dr Olive Shisana, executive director
of the social aspects of HIV/AIDS at the
HRSC, shared national findings that
more than 70% of South African
teachers who know they are infected
Last year more than 4 000
teachers died from HIV and
AIDS-related diseases, 80% of
whom were younger than 45.
‘No one at Goedehoop 
gets sick or dies of AIDS
anymore.’
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Mistrust of the racist system that denied
the majority of South Africans scientific
literacy and proficiency has constrained
evidence-based policy making on
HIV/AIDS and goes a long way
towards explaining why we’ve fallen so
far behind in the battle.
This is the view of leading social
thinker Dr Mamphela Ramphele,
former Director of the World Bank and
former life partner of the security
police-murdered Black Consciousness
hero Steve Biko.
Addressing the closing plenary of the
second national AIDS conference in
Durban last month, Ramphele cited the
initial furore created by the government
having questioned HIV/AIDS causality.
In a speech entitled ‘HIV/AIDS: the
mirror in South Africa’s face’, Ramphele
said that just like Brazil, South Africa
had the depth of scientific know-how
and economic resources to deal a mortal
blow to the disease. However, unlike
Brazil, which unambiguously tackled
the pandemic early on, South Africa
continued to give out confusing
messages and advice to people already
overwhelmed by the trauma of the
disease.
Elaborating on her theory, she added:
‘Our scientists were largely white,
urban based and outside the policy-
making domain of government...we
have a serious problem of mistrust that
prevents us from acknowledging our
problems and using our resources to
address them.’
She said that ‘adding insult to injury’,
the same racist system had over
centuries in many parts of the world
stigmatised black male sexuality as
‘dangerous and driven by
uncontrollable lust’. ‘Unless we
acknowledge the pain of those so
stigmatised, we are unlikely to
overcome our mistrust and build a
better life for all.’
‘Transcend the past’
Those wounded by the past however
needed to transcend it and take
ownership of shaping a ‘future of
dignity’ for all.
In what is to become a feature of the
bi-annual South African AIDS
conference – the Nkosi Johnson
Memorial Lecture – Ramphele made an
impassioned plea for a return to living
the values enshrined in the African
social system of ubuntu and the
governance principles of batho pele
(people first).
As a mirror in the face of South
African society, HIV/AIDS had ‘forced
us to examine the contours of our face
as it really is, and not as we would like
to see it’. Like any face, it bore the scars
of the past, the impact of the current
realities and indications of how the
future was likely to take shape.
HIV/AIDS PANDEMIC – A LEGACY OF CONQUEST
AND MISTRUST 
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Unlike Brazil, which
unambiguously tackled the
pandemic early on, South
Africa continued to give out
confusing messages and
advice to people already
overwhelmed by the trauma of
the disease.
fail to use condoms consistently with
their partners.  A survey of 1 700
teachers revealed that 12.7% of them
were HIV-positive.
Last year more than 4 000 teachers
died from HIV and AIDS-related
diseases, 80% of whom were younger
than 45.  Shisana said that if ART was
provided to 60% of those who needed it,
teacher deaths could be reduced by 18%
by 2010.  She estimates that 23 500
teachers living with HIV have a CD4
cell count below 350.
The national education department
was studying her recommendations and
would release an integrated report on
the demand and supply of teachers at
the end of this month.
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